Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-03

Clinical Trial Update: A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

View source ↗

Summary

Biogen is conducting a study to learn how zuranolone affects postpartum depression symptoms in participants who took it within one year after giving birth. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zuranolone (zuranolone)

Snippet

Sponsor: Biogen | Conditions: Depression, Postpartum | Status: RECRUITING